MX2019005682A - Metodos y dispositivos para la deteccion del virus de la hepatitis c. - Google Patents

Metodos y dispositivos para la deteccion del virus de la hepatitis c.

Info

Publication number
MX2019005682A
MX2019005682A MX2019005682A MX2019005682A MX2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A MX 2019005682 A MX2019005682 A MX 2019005682A
Authority
MX
Mexico
Prior art keywords
methods
virus
devices
hcv
detecting hepatitis
Prior art date
Application number
MX2019005682A
Other languages
English (en)
Inventor
J Clarke Nigel
Rogers Amy
A Leake John
e baumann Russell
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2019005682A publication Critical patent/MX2019005682A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente divulgación proporciona métodos rápidos y no invasivos para determinar si un paciente se beneficiará del tratamiento con agentes terapéuticos que inhiben al virus de la hepatitis C (VHC). Estos métodos se basan en detectar ARN de VHC y/o anticuerpos anti-VHC en muestras de fluidos biológicos secos de pequeño volumen, las cuales son recolectadas utilizando un dispositivo volumétrico absortivo de micromuestreo. Los kits para usarse en la práctica de los métodos también son proporcionados.
MX2019005682A 2016-11-15 2017-11-13 Metodos y dispositivos para la deteccion del virus de la hepatitis c. MX2019005682A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662422321P 2016-11-15 2016-11-15
US201662425263P 2016-11-22 2016-11-22
PCT/US2017/061303 WO2018093721A2 (en) 2016-11-15 2017-11-13 Methods and devices for detecting hepatitis c virus

Publications (1)

Publication Number Publication Date
MX2019005682A true MX2019005682A (es) 2019-10-30

Family

ID=62107725

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005682A MX2019005682A (es) 2016-11-15 2017-11-13 Metodos y dispositivos para la deteccion del virus de la hepatitis c.

Country Status (8)

Country Link
US (2) US20180136211A1 (es)
EP (1) EP3541960A4 (es)
JP (2) JP2020511956A (es)
CN (1) CN110168111A (es)
BR (1) BR112019009798A2 (es)
CA (1) CA3044031A1 (es)
MX (1) MX2019005682A (es)
WO (1) WO2018093721A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110168100A (zh) 2016-11-15 2019-08-23 奎斯特诊断投资有限责任公司 使用mitra尖端提取检测囊性纤维化突变的方法
WO2021216780A1 (en) * 2020-04-21 2021-10-28 Biomerica, Inc. Collection devices for biological samples and methods of use thereof
CN113679701B (zh) * 2020-05-18 2024-04-30 中国科学院上海药物研究所 邻苯三酚及其衍生物作为共价配体反应弹头的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696329B2 (en) * 2006-06-23 2010-04-13 Florida State University Research Foundation, Inc. Immunoglobulin peptides against heated bovine blood
US20130116597A1 (en) * 2011-11-04 2013-05-09 Phenomenex, Inc. Method and apparatus for acquiring blood for testing

Also Published As

Publication number Publication date
JP2022191225A (ja) 2022-12-27
EP3541960A4 (en) 2020-06-10
BR112019009798A2 (pt) 2019-08-06
US20190276904A1 (en) 2019-09-12
EP3541960A2 (en) 2019-09-25
CN110168111A (zh) 2019-08-23
WO2018093721A2 (en) 2018-05-24
JP2020511956A (ja) 2020-04-23
CA3044031A1 (en) 2018-05-24
WO2018093721A3 (en) 2018-06-21
US20180136211A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
WO2018126082A8 (en) Digital microfluidic devices and methods
MX2020004247A (es) Acidos nucleicos libres de celulas para el analisis del microbioma humano y componentes del mismo.
IL258101A (en) Device and system for testing samples, especially blood, and methods for using them
SG11202002931VA (en) Portable molecular diagnostic device and methods for the detection of target viruses
MX2022014633A (es) Metodos para detectar norovirus.
JP1754773S (ja) サンプル採取器具
BR112017017622A2 (pt) reagentes e métodos para a detecção de doenças infecciosas
MX2019005682A (es) Metodos y dispositivos para la deteccion del virus de la hepatitis c.
CA185723S (en) Medical device for processing biological samples
DK3202324T3 (da) Medicinsk anordning til påvisning af mindst én analyt i en kropsvæske
FR3016726B1 (fr) Dispositif pour l'irradiation d'echantillons dans le cœur ou en peripherie du cœur d'un reacteur
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
EA201691682A1 (ru) Способы анализирования редких циркулирующих в крови клеток
MX2019005684A (es) Métodos para detectar mutaciones de fibrosis quística mediante el uso de extracción con puntas mitra.
MX2018011625A (es) Metodos para detectar bordetella.
JP2017526916A5 (es)
NO20045622D0 (no) Apparat for utforelse av behandlingsoperasjoner pa objektglass med vevsprover
Hegazy et al. Hepatitis B vaccination coverage and knowledge among healthcare workers at a tertiary hospital in Jeddah, Saudi Arabia
MA45088A (fr) Méthodes pour traiter des infections par le virus de l'hépatite b au moyen d'inhibiteurs de ns5a, ns5b ou ns3
IL276971A (en) In vitro device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof
CA186285S (en) Medical device for processing biological samples
EA202092156A1 (ru) Модифицированные олигонуклеотиды и способы применения в лечении таупатий
FR2962219B1 (fr) Preleveur d'echantillons notamment liquides et contamines, et appareillage le comprenant
SG11202110642VA (en) Method and device for measuring the fibrinogen concentration in blood samples.
HUE040627T2 (hu) Gyorsteszt testfolyadékokban található humán papilloma vírusok elleni antitestek kvalitatív és/vagy kvantitatív analízisére és a gyorsteszt megvalósítására alkalmas berendezés